Pharmalive - The Pulse of the Pharmaceutical Industry


Search Criteria: Search In:  
Conferences
Favorable Regulatory Procedures in the Netherlands
The Netherlands offers pharmaceutical firms a favorable environment for receiving expedited study review. Clinical studies can be rapidly initiated in The Netherlands due to Dutch government regulations for clinical research. Based on years of experience operating in the Netherlands, this whitepaper will: - Outline the regulatory guidelines for studies in The Netherlands. - Highlight advantages for sponsors conducting studies in The Netherlands. - Provide details on how to appropriately navigate regulatory procedures in The Netherlands.
Provided by: PRA International
Register or Login below to download this and other white papers.
Login to download whitepapers Register To Download Whitepapers
 
Ask The Experts

MedAdNews
Which pharma or biotech company, in your opinion, uses offshoring ...

R&D Directions
What are some recommendations on "fit-for-purpose" best practices ...
How feasible is the nasal route to deliver peptides into the brain ...
Have tangible strides been made in using PET scanning to study ...

Supplements

MedAdNews
Guide to Pharmaceutical Marketing and Interactive Services
Download

Podcasts

BIO’s Big Ideas with James C. Greenwood
Download

The Government and Drug Development with James C. Greenwood
Download

Politics, Approvals, and PhRMA’s Future with John Castellani
Download

Meet Your New President with John Castellani
Download

Download previous episodes

Webcasts

Pharmalot
Infusing Your Knowledge Of The Injectable Drug Delivery Market
May 23, 2011 2:00pm ET | 11:00AM PT
Register Now

View More Webcasts

If you would like to post your white paper on PharmaLive, please contact us.

 


©2010 UBM Canon Pharmaceutical Media Group